Modified GTX as Second-Line Therapy for Advanced Pancreatic Adenocarcinoma

Author： Ajouz Hana   Mukherji Deborah   Haydar Ali   Yakan Ahmad   Saleh Ahmad   Elias Elias   Temraz Sally   Faraj Walid   Khalife Mohammad   Shamseddine Ali  

Publisher： Springer Publishing Company

ISSN： 1941-6628

Source： Journal of Gastrointestinal Cancer, Vol.45, Iss.1, 2014-03, pp. : 109-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current Standard and Future Perspectives in First- and Second-Line Treatment of Metastatic Pancreatic Adenocarcinoma

By  

Digestion, Vol. 94, Iss. 1, 2016-07 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

HIV patients' decision of switching to second-line antiretroviral therapy in India

By  

AIDS Care, Vol. 27, Iss. 7, 2015-07 ,pp. : 900-906

Routledge Ltd

Access to resources Recommend Favorite

How to Proceed in Helicobacter pylori-Positive Chronic Gastritis Refractory to First- and Second-Line Eradication Therapy

By  

Digestive Diseases, Vol. 25, Iss. 3, 2007-09 ,pp. : 203-205

Karger

Access to resources Recommend Favorite

Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 5, Iss. 4, 2016-09 ,pp. : 235-244

Karger

Access to resources Recommend Favorite

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential“ or “concomitant“ treatment to eradicate H. pylori infection

By Gisbert Javier P.  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 6, 2013-06 ,pp. : 652-656

Informa Healthcare

Access to resources Recommend Favorite